Skip to main content
. 2019 Mar 30;6(2):43. doi: 10.3390/medicines6020043

Table 3.

Retention times (RT), MS data, and tentatively identified compounds in the E. japonica extract.

RT (min) [M-H] (m/z) MS/MS (m/z) PDA λmax (nm) Tentative Identification References
11.05 352.96 110.40; 143.67; 179.20; 191.20; 284.50; 312.26 234; 295; 325 probably chlorogenic acid [41]
420.95 259.61; 301.23; 331.19; 343.20; 352.64; 360.36; 375.14; 385.20; 392.55; 403.15 n.c.
17.18 (16.48–17.26) 463.17 151.00; 179.09; 190.34; 221.17; 255.30; 271.50; 300.25; 301.16; 325.03; 343.10; 373.35; 400.93; 418.54; 445.14 234; 347 hyperoside or isoquercetin isomers [42,43]
547.19 220.44; 292.64; 310.81; 384.91; 437.90; 478.82; 500.58; 515.88 n.c.
593.04 255.34; 284.19; 327.19; 411.21; 429.21; 447.18; 473.09; 565.32 n.c.
855.43 417.31; 545.16; 563.31; 691.43; 709.34; 735.38; 864.27 n.c.
901.14 299.82; 439.19; 610.71; 721.14; 763.80; 854.33; 914.59 n.c.
28.12 821.37 511.74; 529.60; 657.60; 675.39; 721.14; 766.16 221; 234; 280 (trans)nerolidol-trirhamnopyranosyl-glucopyranoside or loquatifolin A [44] (compound 1 or 4)
867.12 596.27; 675.92; 690.31; 721.42; 740.66; 786.99; 815.64; 820.05; 833.88 n.c.
1688.98 551.69; 696.87; 719.35; 821.28; 865.28; 881.05; 1275.89; 1396.00; 1541.66 n.c.
29.11 807.37 529.33; 661.43; 675.31 217; 234; 280 unknown new compound [44](compound 2)
853.02 350.34; 454.48; 503.33; 649.33; 731.12; 784.53; 809.49; 839.42; 853.53 n.c.
31.52 675.31 204.97; 307.09; 383.17; 467.33; 529.20; 574.81 221; 234; 283; 312 nerolidol-dirhamnopyranosyl-glucopyranoside [44] (compound 3 or 5)
721.21 490.37; 597.16; 675.29 [M+HCOO-H] of 675.31 [M-H] [44]
33.12-33.67 967.47 309.10; 351.25; 395.15;437.27; 511.25; 529.48; 579.22; 639.41; 657.34; 675.47; 717.98; 743.29; 761.35; 803.44; 821.38; 848.32; 865.41; 922.75; 945.31 334; 289; 323 n.c.
997.51 381.23; 467.03; 511.14; 529.05; 543.22; 567.25; 603.04; 657.15; 675.18; 697.48; 721.08; 773.26; 803.34; 821.36; 833.47; 915.25; 938.24 probably nerolidol--rhamnopyranosyl -rhamnopyranosyl--(4-trans-feruloyl)-rhamnopyranosyl--glucopyranoside [45]
1065.21 405.44; 513.91; 579.73; 675.96; 1020.72; 1033.32; 1041.27; 1057.41; 1067.28 n.c.
50.02 633.52 339.61; 469.47; 487.39; 513.48; 571.44; 589.50; 615.47; 633.50 219; 235; 310 probably 3-O-p-coumaroyltormetic acid [46]
1267.27 1102.55 n.c.
62.90 523.39 - 219; 235; 281 Usolic acid (monomer adduct)* Standard
933.70 408.37; 455.50; 500.98; 584.57; 745.53; 870.99; 933.70 Usolic acid [2M + Na+ -2H+] Standard
1411.83 455.52; 501.44; 933.71; 1302.93; 1377.25; 1410.15 Usolic acid [3M + 2Na+ -3H+] Standard
1885.16 934.78; 1391.11; 1406.28; 1447.24; 1608.90; 1743.24; 1855.24 Usolic acid [4M + 3Na+ -4H+] Standard

All further mass peaks were assumed to be chlorophyll related, because of absorption maxima of 408 nm and higher. n.c.: not classifiable. Fragments shown in bold are the main fragments.* Ursolic acid shows, instead of its monomer ion (m/z 455.50 [M-H+]), an unknown adduct combination (X) with m/z 523.39 [M+X-H+] and forms additional dimer, trimer, and tetramer adducts with Na+ ions.